18.

Gu Y, Liang X, Wu W, Liu M, Song S, Cheng L, et al. Multicenter contracep-

tive ef

ﬁ

cacy trial of injectable testosterone undecanoate in Chinese men. J

Clin Endocrinol Metab 2009;94:1910

–

19.

Shelly W, Draper MW, Krishnan V, Wong M, Jaffe RB. Selective estrogen re-

ceptor modulators: an update on recent clinical

ﬁ

ndings. Obstet Gynecol

Surv 2008;63:163

–

81.

20.

Tenover JS, Bremner WJ. The effects of normal aging on the response of the

pituitary-gonadal axis to chronic clomiphene administration in men. J Androl

1991;12:258

–

63.

21.

Guay AT, Bansal S, Heatley GJ. Effect of raising endogenous testosterone

levels in impotent men with secondary hypogonadism: double blind placebo

controlled trial with clomiphene citrate. J Clin Endocrinol Metab 1995;80:

3546

–

52.

22.

Taylor F, Levine L. Clomiphene citrate and testosterone gel replacement

therapy for male hypogonadism: ef

ﬁ

cacy and treatment cost. J Sex Med

2010;7(1 Pt. 1):269

–

76.

23.

Guay A, Jacobson J, Perez JB, Hodge MB, Velasquez E. Clomiphene in-

creases free testosterone levels in men with both secondary hypogonadism

and erectile dysfunction: who does and does not bene

ﬁ

t? Int J Impot Res

2003;15:156

–

65.

24.

Shabsigh A, Kang Y, Shabsigh R, et al. Clomiphene citrate effects on testos-

terone/estrogen ratio in male hypogonadism. J Sex Med 2005;2:716

–

21.

25.

Turek PJ, Williams RH, Gilbaugh JH III, et al. The reversibility of anabolic

steroid-induced azoospermia. J Urol 1995;153:1628.

26.

Depenbusch M, von Eckardstein S, Simoni M, Nieschlag E. Maintenance of

spermatogenesis in hypogonadotropic hypogonadal men with human cho-

rionic gonadotropin alone. Eur J Endocrinol 2002;147:617

–

24.

27.

Roth MY, Page ST, Lin K, et al. Dose-dependent increase in intratesticular

testosterone by very low-dose human chorionic gonadotropin in normal

men with experimental gonadotropin de

ﬁ

ciency. J Clin Endocrinol Metab

2010;95:3806

–

13.

. C

oAD

oAM

,Am

Anawalt BD, et al. Low-dose human chorionic gonadotropin main-

tains intratesticular testosterone in normal men with testosterone-

induced gonadotropin suppression. J Clin Endocrinol Metab 2005;

90:2595

–

602.

29.

Avila D, Gittens PR, Hwang K, Weedin JW, Rumohr JA, Lipshultz LI. Low dose

human chorionic gonadotropin prevents azoospermia and maintains fertility

in hypogonadal men on testosterone replacement therapy. Poster Session I:

Male Reproductive Urology. Abstract P-120. Presented at the 66th Annual

Meeting of the American Society for Reproductive Medicine, Denver, CO,

Oct 23

–

27, 2010.

30.

Raman JD, Schlegel PN. Aromatase inhibitors for male infertility. J Urol 2002;

167(2 Pt 1):624

–

31.

Ramasamy R, Ricci JA, Palermo GD, Gosden LV, Rosenwaks Z, Schlegel PN.

Successful fertility treatment for Klinefelter's syndrome. J Urol 2009;182:

1108

–

13.

32.

Cakan M, Aldemir M, Topcuoglu M, Altu

g U. Role of testosterone/estradiol

ratio in predicting the ef

ﬁ

cacy of tamoxifen citrate treatment in idiopathic

oligoasthenoteratozoospermic men. Urol Int 2009;83:446

–

51.

33.

Saylam B, Efesoy O, Cayan S. The effect of aromatase inhibitor letrozole on

body mass index, serum hormones, and sperm parameters in infertile men.

Fertil Steril 2011;95:809

–

11.

34.

Burnett-Bowie SA, Roupenian KC, Dere ME, Lee H, Leder BZ. Effects of

aromatase inhibition in hypogonadal older men: a randomized, double-

blind, placebo-controlled trial. Clin Endocrinol (Oxf) 2008;94:4785

–

92.

35.

Guay AT, Perez JB, Fitaihi WA, Vereb M. Testosterone treatment in hypogo-

nadal men: prostate-speci

ﬁ

c antigen level and risk of prostate cancer. Endo-

crinol Pract 2000;6:132

–

36.

Burnett-Bowie SA, McKay EA, Lee H, Leder BZ. Effects of aromatase inhibi-

tion on bone mineral density and bone turnover in older men with low tes-

tosterone levels. J Clin Endocrinol Metab 2009;94:4785

–

92.

724

VOL. 99 NO. 3 / MARCH 1, 2013

ORIGINAL ARTICLE: ANDROLOGY